Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images-Reference-Cited by-同舟云学术

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images

Published:2019-01 Issue:1 Volume:5 Page:610-617
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Sharafi Sayed Mehran¹,Sylvestre Jean‐Philippe²,Chevrefils Claudia²,Soucy Jean‐Paul³,Beaulieu Sylvain⁴,Pascoal Tharick A.⁵,Arbour Jean Daniel⁶,Rhéaume Marc‐André⁶,Robillard Alain⁷,Chayer Céline⁷,Rosa‐Neto Pedro⁸,Mathotaarachchi Sulantha S.⁸,Nasreddine Ziad S.⁹,Gauthier Serge¹⁰,Lesage Frédéric¹¹¹

Affiliation:

1. Genie Electrique Polytechnique MontrealMontrealQuebecCanada

2. Optina DiagnosticsMontrealQuebecCanada

3. Montreal Neurological Institute, McGill UniversityMontrealQuebecCanada

4. Département de médecine nucléaire, Hôpital Maisonneuve‐RosemontMontrealQuebecCanada

5. Translational Neuroimaging Laboratory, McGill Centre for Studies in AgingDouglas Mental Health University InstituteMontrealQuebecCanada

6. Clinique ophtalmologique 2121MontrealQuebecCanada

7. Département de psychiatrieHôpital Maisonneuve‐RosemontMontrealQuebecCanada

8. Translational Neuroimaging LaboratoryMcGill Centre for Studies in Aging Douglas Mental Health University InstituteMontrealQuebecCanada

9. MoCA Clinic and InstituteGreenfield ParkQuebecCanada

10. Alzheimer's Disease Research UnitThe McGill University Research Centre for Studies in AgingMontrealQuebecCanada

11. Research Center, Montreal Heart InstituteMontrealQuebecCanada

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.09.006

Reference55 articles.

1. Alzheimer's disease

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

3. Added value of 18 F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

4. Effect of amyloid imaging on the diagnosis and management of patients with cognitive decline: impact of appropriate use criteria;Grundman M.;Dement Geriatr Cogn Disord,2016

5. [DT‐01–01]: IMPACT OF AMYLOID PET ON PATIENT MANAGEMENT: EARLY RESULTS FROM THE IDEAS STUDY

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic;Alzheimer's Research & Therapy;2024-08-21

2. Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status;Journal of Alzheimer's Disease;2024-08-20

3. Alzheimer's disease pathophysiology in the Retina;Progress in Retinal and Eye Research;2024-07

4. Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial;Acta Neuropathologica Communications;2024-06-28

5. The Crosstalk Between Amyloid-β, Retina, and Sleep for the Early Diagnosis of Alzheimer’s Disease: A Narrative Review;Journal of Alzheimer's Disease Reports;2024-06-25